Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 6,000 shares at $24.50 ($147K) on 2024-06-13, disclosed to the SEC on 2024-06-14.
Scheduled sale ($147k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $440K | — | Filing → |